Poland, Oct. 26 -- Poland based MagnaPharm Poland sp. z o.o. has secured contract from SP ZOZ Centralny Szpital Kliniczny Uniwersytetu Medycznego w Lodzi for Various medicinal products - Delivery of a medicinal product under the B166 drug program for the needs of SP ZOZ CSK UM in Lodz - Wosorytyd. The value of the contract is worth 3276494.82 PLN.
Published by HT Digital Content Services with permission from Pivotal Sources....